MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


AIM WINNERS & LOSERS: Conroy Gold hails Clontibret potential

ALN

The following stocks are the leading risers and fallers on AIM on Friday.

----------

AIM - WINNERS

----------

Conroy Gold & Natural Resources PLC, up 5.8% at 2.75 pence, 12-month range 2.04p-10.70p. The Ireland and Finland-focused gold exploration and development company says two float samples of antinomy mineralisation return ‘very high gold grades’. The samples are from its Clontibret gold deposit area in County Monaghan, Ireland. ‘The discoveries of antimony float which show high gold grades further highlight both the antimony potential of the Clontibret deposit and its correlation to potentially high-grade gold. We are looking forward to exploring the potential of the second antimony trend identified recently to increase the scale of the gold resource within the existing resource footprint,’ Chair John Sherman says.

----------

AIM - LOSERS

----------

Belluscura PLC, down 27% at 0.49p, 12-month range 0.49p-18.00p. The medical device company initiates a strategic review where it will mull options to ‘strengthen its capital position’. Options include ‘potential strategic investment, partnerships, alternative funding structures and other corporate initiatives’, it adds. ‘The review is aimed at supporting both the company’s short-term cash requirements and its longer-term growth and accelerating its path to sustainable profitability. There can be no certainty that the strategic review will result in any specific outcomes, and the company will provide further updates as appropriate. For the avoidance of doubt, the strategic review is not for the purposes of soliciting offers for the company pursuant to the City Code on Takeovers & Mergers,’ Belluscura adds. The firm says the US import tariff on its portable oxygen containers remains at zero. It adds: ‘Despite challenges in late February and March in sourcing product, the company experienced renewed demand for the X-PLOR during April.’ This helped it to a record sales month of $520,000.

----------

Copyright 2025 Alliance News Ltd. All Rights Reserved.